New Triple-Threat pill aims to tame diabetes
NCT ID NCT07441187
Summary
This study is testing a new once-daily pill that combines three different diabetes medications. It aims to see how well it works and how safe it is for controlling blood sugar in 300 Chinese adults with Type 2 diabetes. The study will follow patients for 24 weeks to measure changes in their long-term blood sugar levels and other health markers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM (TYPE 2 DIABETES MELLITUS) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.